Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27605722)

Published in Ghana Med J on March 01, 2016

Authors

Oluseyi A Adejumo1, Enajite I Okaka2, Chimezie G Okwuonu3, Ikponmwosa O Iyawe2, Oluwole O Odujoko3

Author Affiliations

1: Department of Internal Medicine, Kidney Care Centre, Ondo, Ondo State, Nigeria.
2: Department of Internal Medicine, University of Benin Teaching Hospital, Benin, Benin City, Edo State, Nigeria.
3: Department of Internal Medicine, Federal Medical Centre, Umuahia, Abia State, Nigeria.

Articles cited by this

Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis (1998) 10.70

Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation (2003) 8.29

Obesity-induced inflammatory changes in adipose tissue. J Clin Invest (2003) 7.50

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA (2001) 5.54

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA (2001) 4.31

The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med (2004) 2.94

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation (2001) 2.66

Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation (2002) 2.46

Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) (2006) 2.36

The global burden of chronic kidney disease and the way forward. Ethn Dis (2005) 2.14

C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int (2005) 2.13

The malnutrition, inflammation, and atherosclerosis (MIA) syndrome -- the heart of the matter. Nephrol Dial Transplant (2002) 1.82

End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int (2001) 1.61

Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol (2008) 1.44

Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis (2003) 1.42

The enormity of chronic kidney disease in Nigeria: the situation in a teaching hospital in South-East Nigeria. J Trop Med (2010) 1.31

[AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice]. Vnitr Lek (2006) 1.30

High-density lipoprotein: antioxidant and anti-inflammatory properties. Curr Atheroscler Rep (2007) 1.01

Endothelial function, CRP and oxidative stress in chronic kidney disease. J Nephrol (2005) 0.98

Creatinine clearance estimation from serum creatinine values: evaluation and comparison of five prediction formulae in Nigerian patients. Afr J Med Med Sci (2000) 0.96

Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi e Trapianto. Nephrol Dial Transplant (2000) 0.93

Obesity: an independent risk factor for systemic oxidative stress. Pak J Pharm Sci (2006) 0.90

Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation. Curr Pharm Des (2012) 0.88

C-Reactive protein, a valuable predictive marker in chronic kidney disease. Saudi J Kidney Dis Transpl (2009) 0.85

Effects of fluvastatin treatment on lipid profile, C-reactive protein trend, and renal function in dyslipidemic patients with chronic renal failure. Adv Ther (2006) 0.83

High-sensitivity C-reactive protein in subjects with type 2 diabetes mellitus and/or high blood pressure. Arq Bras Endocrinol Metabol (2007) 0.83

Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients Stages 3 and 4: a longitudinal study. Nephrol Dial Transplant (2011) 0.83

Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors. J Nephrol (2012) 0.82

[Relation between paraoxonase activity, other HDL components and inflammatory state in hemodialyzed patients]. Medicina (B Aires) (2010) 0.79

Nontraditional cardiovascular biomarkers and estimation of cardiovascular risk in predialysis chronic kidney disease patients and their correlations with carotid intima media thickness. Nephrourol Mon (2014) 0.78

C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease. J Nephrol (2012) 0.78

Serum CRP levels in pre-dialysis patients. Ren Fail (2008) 0.77